User contributions
(newest | oldest) View (newer 50 | older 50) (20 | 50 | 100 | 250 | 500)
- 22:37, 26 September 2020 (diff | hist) . . (+1,852) . . Ovarian cancer, BRCA-mutated (current)
- 20:53, 26 September 2020 (diff | hist) . . (+236) . . m Breast cancer (current)
- 20:47, 26 September 2020 (diff | hist) . . (+12) . . m Breast cancer - null regimens (→References) (current)
- 20:17, 26 September 2020 (diff | hist) . . (+133) . . m Breast cancer, ER-positive (current)
- 20:08, 26 September 2020 (diff | hist) . . (+387) . . m Breast cancer, HER2-positive (current)
- 19:40, 26 September 2020 (diff | hist) . . (0) . . m Ovarian cancer - null regimens (current)
- 19:34, 26 September 2020 (diff | hist) . . (+1,009) . . m Ovarian cancer - historical (current)
- 19:34, 26 September 2020 (diff | hist) . . (+300) . . m Ovarian cancer - null regimens
- 19:33, 26 September 2020 (diff | hist) . . (+1,438) . . m Ovarian cancer (current)
- 21:46, 25 September 2020 (diff | hist) . . (+1,943) . . m Bladder cancer - null regimens
- 21:45, 25 September 2020 (diff | hist) . . (+6,860) . . m Bladder cancer
- 21:14, 25 September 2020 (diff | hist) . . (+1,120) . . m Breast cancer, triple negative
- 20:49, 25 September 2020 (diff | hist) . . (+937) . . m Follicular lymphoma - historical
- 20:48, 25 September 2020 (diff | hist) . . (+1,133) . . m Follicular lymphoma
- 18:40, 25 September 2020 (diff | hist) . . (+488) . . m Renal cell carcinoma
- 16:43, 25 September 2020 (diff | hist) . . (+9,653) . . m Breast cancer (→Adjuvant chemotherapy)
- 12:34, 25 September 2020 (diff | hist) . . (+1,551) . . m Prostate cancer - null regimens
- 12:33, 25 September 2020 (diff | hist) . . (+1,629) . . m Prostate cancer
- 22:48, 24 September 2020 (diff | hist) . . (+9) . . m Chronic lymphocytic leukemia
- 22:46, 24 September 2020 (diff | hist) . . (+598) . . m Chronic lymphocytic leukemia - historical
- 22:46, 24 September 2020 (diff | hist) . . (+3,156) . . m Chronic lymphocytic leukemia
- 22:12, 24 September 2020 (diff | hist) . . (-59) . . m Bleeding disorders and risk (current)
- 21:46, 24 September 2020 (diff | hist) . . (+112) . . m Acute myeloid leukemia (→"How I Treat")
- 21:16, 24 September 2020 (diff | hist) . . (+106) . . m Anemia (→Guidelines) (current)
- 20:58, 24 September 2020 (diff | hist) . . (+227) . . m Temozolomide (Temodar) (→History of changes in FDA indication) (current)
- 20:56, 24 September 2020 (diff | hist) . . (+1,099) . . N Alitretinoin (Panretin) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/alitretinoin NCI Drug Dictionary]: An orally- and topically-active naturally...") (current)
- 20:52, 24 September 2020 (diff | hist) . . (-6) . . m Samarium-153 (Quadramet) (→History of changes in FDA indication) (current)
- 20:51, 24 September 2020 (diff | hist) . . (+74) . . m Strontium-89 (Metastron) (→History of changes in FDA indication) (current)
- 20:44, 24 September 2020 (diff | hist) . . (+1,259) . . m Acute myeloid leukemia - historical
- 20:44, 24 September 2020 (diff | hist) . . (+3,216) . . m Acute myeloid leukemia
- 20:41, 24 September 2020 (diff | hist) . . (-1) . . m Stub (→FLAI)
- 20:41, 24 September 2020 (diff | hist) . . (+250) . . m Stub (→FLAI)
- 20:12, 24 September 2020 (diff | hist) . . (+98) . . m Anemia (→"How I treat")
- 19:40, 24 September 2020 (diff | hist) . . (+112) . . m Anemia (→"How I treat")
- 19:28, 24 September 2020 (diff | hist) . . (+154) . . m Anemia (→Initial evaluation)
- 16:20, 24 September 2020 (diff | hist) . . (+92) . . m Stub (→FLAI)
- 09:47, 24 September 2020 (diff | hist) . . (+302) . . m Stub (→FOLF-CB)
- 09:44, 24 September 2020 (diff | hist) . . (+351) . . m Stub (→AME)
- 09:41, 24 September 2020 (diff | hist) . . (-296) . . m Stub (→AIE)
- 09:35, 24 September 2020 (diff | hist) . . (+598) . . m Stub (→Bortezomib & Bevacizumab)
- 22:26, 22 September 2020 (diff | hist) . . (+197) . . m Vinorelbine (Navelbine) (→History of changes in FDA indication) (current)
- 22:24, 22 September 2020 (diff | hist) . . (+133) . . m Teniposide (Vumon) (→History of changes in FDA indication) (current)
- 22:21, 22 September 2020 (diff | hist) . . (+90) . . m Pentostatin (Nipent) (→History of changes in FDA indication) (current)
- 22:20, 22 September 2020 (diff | hist) . . (+234) . . m Pegaspargase (Oncaspar) (→History of changes in FDA indication) (current)
- 22:19, 22 September 2020 (diff | hist) . . (+114) . . m Paclitaxel (Taxol) (→History of changes in FDA indication) (current)
- 22:16, 22 September 2020 (diff | hist) . . (+258) . . m Octreotide (Sandostatin) (current)
- 22:15, 22 September 2020 (diff | hist) . . (-27) . . m Drug index (→N) (current)
- 22:14, 22 September 2020 (diff | hist) . . (+27) . . m Drug index (→N)
- 22:13, 22 September 2020 (diff | hist) . . (+198) . . m Nilutamide (Nilandron) (current)
- 22:10, 22 September 2020 (diff | hist) . . (+161) . . m Mitoxantrone (Novantrone) (→History of changes in FDA indication) (current)
(newest | oldest) View (newer 50 | older 50) (20 | 50 | 100 | 250 | 500)
